Farmas USA

In solo caso de RSV en toda la comunitat...
Y el cambio de cepa de la B a la A... Gracias x el link

Pues ya somos tres ....los que pensamos igual ...mis DVAX con orden de venta en 11,30...me da un 67% de probabilidades de que se de , y eso es síntoma de montaña Rusa...eso sí , hoy intentaré estar quieto...salvo caídas importantes , para comprar ....😉

y a riesgo de ser pesado, IBB mensual, la alcista esta bien clara.

Nvax
Todos los informes disponibles
http://www.vhebron.net/informes-setmanals-de-vrs

67% ?

vaya sistema tienes , todavia no te da la probabilidad con decimales?

eso hay que mejorarlo, eh?

;)

DVAX
Magura a mi el calculo me da que va tocar los 11.68. A ver si consigo adivinar ese sistema que usa tu,je,je,je

ACAD
A ver si hay rebote de verdad. La gráfica es de echarse a temblar

TGTX

Los buitres, como siempre.

Levi & Korsinsky, LLP announces that it has commenced an investigation of TG Therapeutics, Inc. (TGTX) concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors.

TG Therapeutics, Inc. filed a press release on October 13, 2016 announcing that the Company had filed with the FDA an amended protocol for its leukemia drug combination, GENUINE Phase 3 Trial. In the amendments, the Company eliminated part II of the GENUINE study and reduced the number of randomized patients from 200 to approximately 120. The Company no longer benefits from of its previously negotiated Special Protocol Assessment with the FDA. Following this news, TG Therapeutics, Inc. stock dropped approximately 17% (-$1.42) to $6.83 per share on intraday trading.

http://finance.yahoo.com/news/investor-alert-levi-korsinsky-llp-131700207.html